Prod'homme Chloé, Bommier Côme, Fenwarth Laurène, Moreau Stephane, Polomeni Alice
Univ. Lille, ULR 2694 METRICS, CHU Lille, Palliative care unit, Lille, F-59000, France.
Hôpital St Louis, Inserm U1153 ECSTRRA Team, Hémato-Oncologie DMU DIH, Paris, F-75010, France.
BMC Palliat Care. 2025 Jan 31;24(1):32. doi: 10.1186/s12904-025-01659-9.
Haematology is a speciality frequently confronted with end-of-life situations, and teams will be concerned by the question of medical assistance in dying. The Ethics Commission of the French Society of Haematology has conducted a survey on the knowledge and perceptions of healthcare professionals regarding complex end-of-life situations.
A cross-sectionalonline survey of hematology professionals in France. The comprehensive online questionnaire addressed respondents' experience of complex end-of-life situations in hematology, based on 7 clinical vignettes. The survey contained 55 questions, 6 of which were open-ended. They were asked to give their opinion on whether it should be legalized. Justifications were then requested and analyzed by theme.
The survey was distributed to associations of hematology healthcare professionals (approximately 1,300 members). Overall, 182 healthcare professionals replied, including a third nurses and a third physicians. The average score for identifying complex situations was 7.1 out of 10 (IQR 5.7,8.6), with lesser knowledge of situations involving double effect, euthanasia and sedation for distress than of situations involving limiting or stopping treatment. Training in palliative care was the main driver of knowledge (p = 0.004), as well as being a physician (p < 0.001). We found that the opinions of healthcare professionals regarding the legalization of medical assistance in dying in France were diverse and well-founded.
Hematology healthcare professionals had lesser knowledge of situations involving double effect, euthanasia and sedation for distress. Knowledge of specific situations impacts professionals' opinion on legalization of medical assistance in dying.
血液学是一个经常面临临终情况的专业领域，团队会关注医疗协助死亡的问题。法国血液学会伦理委员会对医疗保健专业人员关于复杂临终情况的知识和看法进行了一项调查。
对法国血液学专业人员进行横断面在线调查。综合在线问卷基于7个临床案例，询问了受访者在血液学复杂临终情况方面的经验。该调查包含55个问题，其中6个为开放式问题。要求他们就是否应将其合法化发表意见。然后要求给出理由并按主题进行分析。
该调查已分发给血液学医疗保健专业人员协会（约1300名成员）。总体而言，182名医疗保健专业人员进行了回复，其中三分之一是护士，三分之一是医生。识别复杂情况的平均得分为7.1分（满分10分，四分位距为5.7,8.6），与涉及限制或停止治疗的情况相比，对涉及双重效应、安乐死和痛苦镇静的情况了解较少。姑息治疗培训是知识的主要驱动因素（p = 0.004），医生身份也是如此（p < 0.001）。我们发现，医疗保健专业人员对法国医疗协助死亡合法化的意见各不相同且有充分依据。
血液学医疗保健专业人员对涉及双重效应、安乐死和痛苦镇静的情况了解较少。对特定情况的了解会影响专业人员对医疗协助死亡合法化的看法。
